SINOPHARM (01099) Announces First Three Quarters Results, Net Profit Attributable to Parent 5.314 Billion Yuan, Up 0.13% Year-on-Year
Sinopharm Group (01099) announced its results for the nine months ended September 30, 2026. During the period, the Group recorded operating revenue of RMB 427.613 billion, a year-on-year decrease of 0.9%; net profit attributable to owners of the parent company was RMB 5.314 billion, a year-on-year increase of 0.13%; and basic earnings per share were RMB 1.7.
SINOPHARM (01099) announced its results for the nine months ended September 30, 2026. During the period, the Group recorded operating revenue of RMB 427.613 billion, a year-on-year decrease of 0.9%; net profit attributable to owners of the parent company was RMB 5.314 billion, a year-on-year increase of 0.13%; and basic earnings per share were RMB 1.7.
Related Articles
GMTEight List of A-share restricted sales and lifting restrictions | October 26
Brokerage Morning Meeting Highlights | The computing power industry is still growing but will return to rationality.
HAITONG UT (01905): H shares will resume trading on October 26.
GMTEight List of A-share restricted sales and lifting restrictions | October 26
Brokerage Morning Meeting Highlights | The computing power industry is still growing but will return to rationality.
HAITONG UT (01905): H shares will resume trading on October 26.
